Lindner Center of HOPE in affiliation with the University of Cincinnati (UC) College of Medicine conducts advanced research in genetics, brain imaging, psychopharmacology, psychotherapy, and health service delivery. This research provides new methods to better prevent, diagnose and treat common mental illnesses like schizophrenia, major depression, bipolar disorder, eating and weight disorders, anxiety disorders, attention deficit hyperactivity disorder, and cognitive and memory problems in adolescents, adults and senior individuals. Research studies and the advances they lead to are closely integrated into the evidence-based treatment programs provided at Lindner Center of HOPE. Historically, there has been a 17-year lag time before research findings are integrated with the diagnosis and treatment of patients. However, at Lindner Center of HOPE, research informs patient care each and every day.
Nationally and internationally regarded clinician-scientists at the Research Institute work in collaboration with top investigators at the University of Cincinnati College of Medicine and other leading academic research institutions around the country.
Our clinician-scientists have published over 800 scientific articles, received over $15 million in grants at UC, and $2 million in grants since opening. Lindner Center of HOPE researchers have been instrumental in bringing six new drugs to market for depression and bipolar disorder for improved therapeutic efficacy and safety.
In 2010, the Brain Imaging Center
at Lindner Center of HOPE, in partnership with the University of Cincinnati College of Medicine Center for Imaging Research
, launched research efforts to further understand the disorders of the brain through the use of a Philips 3.0 Tesla (3T) MRI scanner and its unparalleled views of the brain.
As charter members of the National Network of Depression Centers (NNDC
), the Research Institute at Lindner Center of HOPE plays a leading role in fostering breakthroughs in the field of mental health, while contributing to information sharing and rapid translation of new treatments into clinical settings of the network’s members nationwide.
In addition, the Research Institute is a member of the Harvard-based Clinical Trial Network.